286 related articles for article (PubMed ID: 28258492)
1. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T
Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492
[TBL] [Abstract][Full Text] [Related]
2. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
3. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
[TBL] [Abstract][Full Text] [Related]
4. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
Dong L; Li Y; Xue D; Liu Y
IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839
[TBL] [Abstract][Full Text] [Related]
5. Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
Du E; Zhang C; Qin Z; Yang K; Li C; Wang A; Zhang Z; Xu Y
Urol Oncol; 2017 Apr; 35(4):152.e7-152.e12. PubMed ID: 28161324
[TBL] [Abstract][Full Text] [Related]
6. Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
Bao Y; Liu X; Liu Y; Wang S; Wu B
Surg Oncol; 2019 Sep; 30():63-71. PubMed ID: 31500788
[TBL] [Abstract][Full Text] [Related]
7. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
Wang FH; Ma XJ; Xu D; Luo J
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
[TBL] [Abstract][Full Text] [Related]
8. P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
Li W; Ye L; Chen Y; Chen P
World J Surg Oncol; 2018 Oct; 16(1):206. PubMed ID: 30322400
[TBL] [Abstract][Full Text] [Related]
9. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
10. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
11. Amyloid precursor protein is overexpressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
Zhang D; Zhou C; Li Y; Gao L; Pang Z; Yin G; Shi B
Int J Urol; 2018 Sep; 25(9):808-816. PubMed ID: 30021247
[TBL] [Abstract][Full Text] [Related]
12. Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
Asai A; Miyata Y; Takehara K; Kanda S; Watanabe SI; Greer PA; Sakai H
J Cancer Res Clin Oncol; 2018 Jan; 144(1):21-31. PubMed ID: 28952025
[TBL] [Abstract][Full Text] [Related]
13. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
16. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
[TBL] [Abstract][Full Text] [Related]
17. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in urinary bladder transitional cell carcinoma and its association with clinicopathological characteristics.
Tabriz HM; Olfati G; Ahmadi SA; Yusefnia S
Asian Pac J Cancer Prev; 2013; 14(8):4539-43. PubMed ID: 24083698
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
Shang C; Guo Y; Zhang H; Xue YX
Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
Liu Y; Wang H; Zhong J; Wu C; Yang G; Zhong Y; Zhang J; Tang A
BMC Cancer; 2018 Jun; 18(1):642. PubMed ID: 29880037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
